The research group behind Reccan Diagnostics receives SWELife/Vinnova funding of 1.5 MSEK "Development of a novel diagnostic and prognostic biomarker panel in blood in pancreatic cancer"
Utveckling av en ny diagnostisk och prognostisk biomarkörpanel i blod vid pankreascancer
